Filing Details
- Accession Number:
- 0000315066-12-003785
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-20 09:24:37
- Reporting Period:
- 2012-07-17
- Filing Date:
- 2012-07-20
- Accepted Time:
- 2012-07-20 09:24:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1446847 | Ironwood Pharmaceuticals Inc | IRWD | Pharmaceutical Preparations (2834) | 043404176 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
315066 | Fmr Llc | 82 Devonshire Street Boston MA 02109 | No | No | Yes | Yes | |
318989 | Ltd Fil | P.o. Box H.m. 670 Hamilton D0 00000 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2012-07-17 | 7,903 | $13.63 | 2,297,675 | No | 4 | S | Indirect | Footnote |
Class A Common Stock | Disposition | 2012-07-18 | 18,060 | $13.40 | 2,279,615 | No | 4 | S | Indirect | Footnote |
Class A Common Stock | Disposition | 2012-07-19 | 47,252 | $13.35 | 2,232,363 | No | 4 | S | Indirect | Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Footnote |
No | 4 | S | Indirect | Footnote |
No | 4 | S | Indirect | Footnote |
Footnotes
- Column 5 Amount of Securities Beneficially Owned Following Reported Transaction is held by Impresa Fund II LLC (921,661 Class A Common Stock), Impresa Fund III Limited Partnership (74,798 Class A Common Stock), Fidelity Biosciences Corp. (10,971 Class A Common Stock) and FIL Limited (1,224,933 Class A Common Stock). Column 5 does not include shares beneficially owned by Fidelity Management & Research Company as a result of acting as investment adviser to various investment companies as disclosed in Remark 1 below.
- The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $13.34 to $13.75. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.